Further Decision Processed by IB
04/19/2025
Back to search
Official data from USPTO
RYZENGO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
05/14/2025
Trademark type
Word
Nice classes
5
Filing date
06/03/2016
Registration date
11/15/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/26/2023
Last transaction
05/14/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
THOMAS, JULIE
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Novartis AG
Representatives
Novartis Pharma AG, Trademark Department
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma
Publications
History of USPTO decisions and trademark events.
22 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/30/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
03/30/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
03/30/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/26/2024
C71T
CANCELLED SECTION 71
05/26/2023
GPNX
NOTIFICATION PROCESSED BY IB
10/27/2017
GPNX
NOTIFICATION PROCESSED BY IB
04/07/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/15/2016
FIMP
FINAL DISPOSITION PROCESSED
12/15/2016
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
12/15/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
11/15/2016
PUBO
PUBLISHED FOR OPPOSITION
08/30/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/10/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/10/2016
NPUB
NOTICE OF PUBLICATION
08/10/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/28/2016
DOCK
ASSIGNED TO EXAMINER
07/22/2016
MAFR
APPLICATION FILING RECEIPT MAILED
07/16/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/12/2016
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/11/2016
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
07/07/2016
Continuous trademark protection
Get notified about every new filing that threatens RYZENGO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.